This article is part of Med Tech Outlook's Innovation Insights series featuring expert contributions nominated by our subscribers and reviewed by our editorial team.

How Noble Brings Patient Voices to the Center of Medical Device Innovation

Madeline Wehrle, Manager, User Experience Services , Noble International

Patient Experience Champion

Editor’s Note: Enterprise MedTech leaders must rethink device innovation strategies to prioritize real-world usability and regulatory alignment in increasingly complex care environments. This perspective underlines the growing strategic importance of embedding patient insights early to reduce risk, accelerate approvals, and drive meaningful adoption.

In today’s rapidly evolving MedTech landscape, the stakes for medical device development have never been higher. Regulatory expectations continue to intensify, user populations grow more diverse, and clinical environments become more complex. Yet, despite these pressures, one truth remains constant: a device cannot succeed if it is not optimally designed for the people who rely on it.

For more than 30 years, Noble has championed this philosophy, grounding every design decision in real-world human experience. By uniting deep human factors expertise, device development and strategy with global user research, the team ensures medical devices are not only safe and effective, but intuitive, inclusive, and aligned to the actual needs of patients, caregivers, and clinicians to drive market uptake and differentiation.

This approach is not an overlay or a stage gate; it is the foundation. And in a regulatory environment where user needs, risk mitigation, and intuitive use are directly tied to submission success, it is also a strategic advantage.

Why Users Voices Must Lead Device Strategy

Too often, device teams rely heavily on technical requirements or platform familiarity when evaluating device options. While these inputs matter, they rarely reflect what determines everyday usability. When patient needs are overlooked, or worse, assumed, errors surface late, validation studies fail, and launches stall.

Anchoring early decisions in authentic patient insights, what people actually do, feel, and struggle with, creates clarity that reduces risk across the development lifecycle. Their work demonstrates that the earlier these insights are captured and translated into design criteria, the more confidently teams can design, test, and validate devices in alignment with regulatory expectations.

This patient-first foundation has supported more than 40 successful HF submissions and over 30,000 hours of global research across diverse populations, from pediatrics to aging users.

Human Factors as a Strategic Accelerator—Not a Checkbox

Human Factors engineering has become a decisive factor in regulatory decision making. Agencies increasingly expect clear alignment between:

• User needs
• Design decisions
• Intended use
• Risk mitigation
• Training and IFUs

When these elements are not clearly connected, submissions stall, sometimes fatally. As Noble’s UX Services team emphasizes, “Regulators want to see alignment, not assumptions.” They close this gap by ensuring user needs and risks are defined early and addressed holistically across product, packaging, labeling, and training.

Noble adds decades of specialized expertise in ergonomics, cognitive science, anthropometrics, and behavioral observation. Their approach captures what users can do, what they think they do, and what they actually do, an essential distinction that frequently reshapes design direction.

This combination, early patient voice + rigorous human performance science, translates into submissions that are more complete, more defensible, and less vulnerable to late-stage redesigns.

From Insight to Design to Training: A Fully Connected UX Ecosystem

The strength of Noble’s offering lies not only in their research acumen, but in their ability to translate insights into design strategy, and to ensure those strategies carry through onboarding, labeling, and training.

1. Defining User Needs & Guardrails
Through global contextual research, simulated use testing, and ergonomic measurement, the team identifies the physical, cognitive, sensory, and emotional realities that shape device interaction. This ensures design requirements, risk analyses, and device guardrails reflect applied use imitations, not idealized use cases.

2. Human-centered Design Development
Noble’s expertise in ergonomic medical design is evident in signature projects across surgical consoles, drug delivery systems, diagnostics, and disposables. Their design process balances biomechanics, anthropometrics, and intuitive interaction, shaping devices that seamlessly integrate into the hand, the workflow, and the moment of use.

3. Integrated Training & IFU Strategy
Noble ensures that user centered design does not end at the device. Clear, behavior-based training and labeling are essential components of safe and effective use, especially in high stress, emergency, or at-home settings.

Their human factors approach informs:

• IFU layout and iconography
• Training kits
• Digital and specialty pharmacy supported onboarding
• Emergency scenario communication

This integration reduces cognitive load, improves comprehension, and closes usability gaps that can introduce residual risk.

Global Human Performance Labs: Where Authentic Behavior Comes into Focus

Around the globe, Noble teams observe hands-on behavior in controlled, immersive environments, ranging from clinical workflows to in-home simulations. These labs allow teams to uncover hidden challenges that users may never articulate, directly informing safer and more intuitive device design.

This capability is particularly valuable for:

• Emergency use devices
• Wearables
• Drug delivery platforms
• Diagnostics
• Pediatric or aging populations
• Global market launches

By recreating field-based context, they ensure that design validation is grounded in human truth rather than theoretical assumptions.

The Result: Devices Engineered for Safety, Adoption, and Regulatory Success

Across hundreds of programs, Noble has demonstrated that when human-centered design is embedded from the start, outcomes improve across the board:

• Clearer device strategy
• Fewer late-stage redesigns
• Higher usability and satisfaction
• Stronger IFUs and training
• Smoother regulatory pathways
• More confident launch readiness

Their work underscores a broader truth for the MedTech industry: Human factors is not merely a regulatory requirement, it is a catalyst for safety, trust, and market differentiation.

Conclusion: Designing Devices for the Real World

As medical technology continues to evolve, success will increasingly depend on a team’s ability to bridge human experience with regulatory clarity. By elevating the voice of the patient and grounding design in human reality, Noble is helping shape a future where medical devices are not just compliant, but empathetic, intuitive, and truly fit for life.

About Noble
Noble brings more than 30 years of human centered design and human factors expertise, supported by 40+ regulatory submissions and 30,000+ hours of global user research. Their work spans key therapeutic and device categories across leading pharmaceutical and MedTech brands-centered design and human factors expertise

Learn more at www.gonoble.com.

MORE FROM INNOVATION INSIGHTS

Laser welding of plastics in medical technology

Evosys North America Corporation

Mr. Denis Wittmaier, CEO

EXPLORE OUR KNOWLEDGE NETWORK

View Innovation Insights Read Leadership Perspectives

The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

How Noble Brings Patient Voices to the Center of Medical Device Innovation

This combination, early patient voice + rigorous human performance science, translates into submissions that are more complete, more defensible, and less vulnerable to late-stage redesigns.

MORE FROM INNOVATION INSIGHTS

Laser welding of plastics in medical technology

Top 5 medtech UX predictions

Predictions for Upcoming Business & Technology Trends in 2021

Outlook 2021 from CellFree Sciences Co., Ltd.

EXPLORE OUR KNOWLEDGE NETWORK